Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections

Raad, Issam; R. Graybill, John; B. Bustamante, A.; A. Cornely, Oliver; Alejandra Gaona-Flores, Verónica; Afif, Claude; R. Graham, Donald; N. Greenberg, Richard; Hadley, Susan; Langston, Amelia; Negroni, Ricardo; R. Perfect, John; Pitisuttithum, Punnee; Restrepo, Ángela; J. Schiller, Gary; D. Pedicone, Lisa; J. Ullmann, Andrew

doi:10.1086/504328

Public

Safety of Long-Term Oral Posaconazole Use in the Treatment of Refractory Invasive Fungal Infections

Published in Clinical Infectious Diseases • May 18, 2006

Authors:

Issam Raad

John R. Graybill

A. B. Bustamante

Abstract

BACKGROUND: Invasive fungal infections are found most frequently in immunosuppressed and critically ill hospitalized patients. Antifungal therapy is often required for long periods. Safety data from the clinical development program of the triazole antifungal agent, posaconazole, were analyzed. METHO...

Subject

Posaconazole

Adverse effect

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!